Read + Share
Amedeo Smart
Independent Medical Education
Zhang H, Nabel CS, Li D, O'Connor RI, et al. Histone deacetylase 6 inhibition exploits selective metabolic vulnerabilities in LKB1 mutant, KRAS driven non-small cell lung cancer. J Thorac Oncol 2023 Mar 21:S1556-0864(23)00197.PMID: 36958689
Email
LinkedIn
Facebook
Twitter
Privacy Policy